Quick Answer
Insight Molecular Diagnostics Inc. reported Common Stock Shares Outstanding of 28.68 million shares for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +64.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Insight Molecular Diagnostics Inc.'s Common Stock Shares Outstanding has grown by 13.0%.
- Historical annual values: Fiscal year 2025: 28.68 million shares | Fiscal year 2024: 17.45 million shares | Fiscal year 2023: 8.26 million shares | Fiscal year 2022: 5.93 million shares | Fiscal year 2021: 92.23 million shares | Fiscal year 2020: 69.12 million shares | Fiscal year 2019: 57.03 million shares | Fiscal year 2018: 40.66 million shares | Fiscal year 2017: 31.45 million shares | Fiscal year 2016: 28.74 million shares | Fiscal year 2015: 25.39 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: